RAC1 and melanoma: Recently, Lodde and collaborators showed the largest group of RAC1-mutated melanoma patients reported so far (n = 64), with RAC1 mutation identified in approximately 2% of samples; the most frequent was PS9S; 84% were cutaneous melanoma, and 14% of unknown primary [38].